perindopril has been researched along with Endomyocardial Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Aizawa, Y; Ali, F; Hasegawa, G; Hirabayashi, K; Kodama, M; Ma, M; Nagai, Y; Naito, M; Nakazawa, M; Narasimman, G; Saito, Y; Shirai, K; Soga, M; Suresh, P; Tachikawa, H; Takahashi, T; Wahed, M; Watanabe, K; Wen, J; Yamaguchi, K | 1 |
| Michel, JB | 1 |
2 other study(ies) available for perindopril and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy.
Topics: Administration, Oral; Angiotensin I; Animals; Cardiomyopathy, Dilated; Collagen Type III; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Endomyocardial Fibrosis; Gene Expression; Heart Failure; Hemodynamics; Hypertension; Infusions, Intravenous; Male; Pericardial Effusion; Perindopril; Rats; Rats, Inbred Lew; RNA, Messenger; Survival Rate; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Pressure | 2003 |
Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac hypertrophy and congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Collagen; Disease Models, Animal; Endomyocardial Fibrosis; Gene Expression; Heart Failure; Hypertension; Indoles; Male; Myocardial Contraction; Myocardial Infarction; Myosins; Organ Size; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; RNA, Messenger | 1990 |